# David Whitcombe

> David Whitcombe is a startup investor at GM&C Life Sciences Fund (Manchester). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [GM&C Life Sciences Fund](https://shizune.co/investors/profile/gm-c-life-sciences-fund)
- Location: Manchester, United Kingdom
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/david-whitcombe-3b28095/

David Whitcombe is a startup investor at GM&C Life Sciences Fund in Manchester. David is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow.David is a well-known consultant and non-executive director/Chairman who co-founded DxS Diagnostics in 2000 to exploit a personalised medicinetechnology he had invented while with AstraZeneca Diagnostics. DxS was sold to Qiagen in September 2009 for in excess of £100m. Prior to DxS, David was Head of Technology Development at AstraZenica Diagnostics for four years where he led a team of up to 15 scientists working on new genome technologies.David began his career as a Post-Doctoral Fellow with Warwick University Department of Biological Sciences, before joining Cambridge University Department of Medicine as a Senior Post-Doctoral Fellow where he researched the Genetics of Human Disease for six years.David holds a First Class BSc in Genetics from the University of York and PhD in Biochemistry/Molecular Biology from the University of Leicester.

## About GM&C Life Sciences Fund

VC Fund · Alderley Edge, United Kingdom

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

5 contacts available at GM&C Life Sciences Fund.

| Name | Title | Profile |
| --- | --- | --- |
| David Whitcombe | Venture Partner | https://shizune.co/investors/profile/david-whitcombe |
| David Whitcombe | Venture Partner | https://shizune.co/investors/profile/david-whitcombe-15de |
| Chris Spencer | Venture Partner | https://shizune.co/investors/profile/chris-spencer-2bb3 |
| Gareth King | Life Science Partner | https://shizune.co/investors/profile/gareth-king |
| Kevin D'Silva | Venture Partner - Medical Devices | https://shizune.co/investors/profile/kevin-d-silva |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co